ORAL COMPOSITIONS

Abstract: The invention relates to oral compositions such as toothpastes which contain Vitamin C and a copper compound such as coppersulphate. The tendency of these compositions to discolour, particularly if they also contain a zinc compound such as zinc citrate, can be reduced by the inclusion in the compositions of a stannous compound such as stannouspyrophosphate.

Description: The present invention relates to oral compositions such as mouthwashes, dentifrices, toothpastes, teeth cleaning powders and tablets, gels for the treatment of teeth etc. More particularly, it relates to oral compositions which contain as essential ingredients Vitamin C or a derivative thereof, such as a salt or an ester, and a copper compound which is capable of releasing copper ions such as water soluble copper (II) salts. Such oral compositions have been described and claimed in our European patent application 0 321,282, published on 21 June 1989. Although these compositions are relatively stable, effective products for the control of gingivitis and/or periodontitis, they show a tendency to discolour, mainly at the surface of the product, not only when exposed to air upon extrusion of the toothpaste from the container, but also during storage of the toothpaste in a closed container at various temperatures. In our above EP 0 321,282 it is recommended to minimize the slight discolouration of an extruded toothpaste ribbon by formulating the toothpaste to give a lower pH of from about 4 to about 5. We have now surprisingly found, that such discolouration can also be prevented or reduced to a significant degree by inclusion in these oral compositions of a stannous compound, capable of releasing stannous ions in the compositions. Not only is the discolouration of the toothpaste when exposed to air upon extrusion from the container significantly reduced, but also the discolouration of the toothpaste which may occur in the container during storage of the toothpaste in the container. Consequently, the present invention in its broadest aspect relates to an oral composition comprising vitamin C or a salt or an ester thereof, and a copper compound, capable of releasing copper ions, said composition having a reduced tendency to discolour upon storage and upon exposure to air, characterised in that it further contains an effective amount of a stannous compound, capable of releasing stannous ions. We have further found, that the present invention is of particular benefit when the oral composition also contains a zinc compound. Compositions, which contain Vitamin C, a copper compound and a zinc compound have a greater tendency to discolour, and by inclusion of the stannous compound said discolouration is also significantly reduced. The stannous compound, useful in the present invention, can be any inorganic and/or organic stannous compound, capable of releasing stannous ions. Typical examples of suitable stannous compounds are stannous fluoride, stannous chloride, stannous chloride fluoride, stannous acetate, sodium stannous fluoride, potassium stannous fluoride, stannous hexafluorozirconate, stannous sulfate, stannous tartrate, stannous gluconate, stannous pyrophosphate, stannous metaphosphate, stannous oxalate, stannous phosphate etc. Stannous fluoride, and particularly stannous pyrophosphate are the preferred stannous salts. Mixtures of various stannous salts may also be used. A preferred mixture is the mixture of stannous fluoride and stannous pyrophosphate. The stannous compound is generally used in an amount of 0.01-10% by weight of the composition, usually 0.02-5% by weight and preferably 0.1-3% by weight. The oral compositions of the present invention containing Vitamin C, or a salt or ester thereof, a copper compound capable of releasing copper ions and other ingredients are substantially of the same type as more fully described in our aforesaid EP 0 321,282. Thus, the Vitamin C, or salt or ester thereof, is present in the product of the invention in an amount of from 0.05% to 5%, preferably 0.5% to 5% by weight of the product. A mixture of two or more of ascorbic acid, ascorbic salt and ascorbic acid ester may of course be used. Any physiologically acceptable salt of ascorbic acid may be used. Various alkali metal and alkaline earth metal salts are suitable. Other suitable salts are the ammonium salt and those derived from monoethanolamine, diethanolamine, and amino acids such as arginine and lysine. Suitable ascorbic acid esters are those in which one or more hydroxy groups in the 2-, 3,-, 5- and/or 6-positions are fatty acid ester, sulphate or phosphate. Examples are ascorbic acid-2-acetate, ascorbic acid-2-sulphate, ascorbic acid-2-phosphate, ascorbic acid-2-palmitate. The copper compound is preferably incorporated in the product of the invention in the form of a water-soluble copper salt to provide copper ions in the aqueous liquid medium of the toothpaste. Any suitable physiologically acceptable salt may be used. Examples of suitable copper salts are copper sulphate, copper halides and pseudohalides, copper nitrate, copper salts of carboxylic acids in the homologous series formic acid to decanoic acid, copper salts of polybasic acids in the series oxalic acid to suberic acid, and copper salts of hydroxycarboxylic acids including glycolic acid, lactic acid, tartaric acid, malic acid and citric acid. The copper compound may also be included in the toothpaste of the invention in the form of a copper compound precipitated on a solid or colloidal support such as silica, a clay (e.g. montmorillonite) or upon a biopolymer or synthetic polymer. Copper compounds which are substantially insoluble but which nevertheless release sufficient copper ions, such as copper hydrotalcite, may also be used. The amount of copper compound, calculated as copper, which is included in compositions according to the present invention ranges from 1 ppm to 1000 ppm, preferably 10 to 200 ppm, more preferably 30 to 100 ppm. Examples of zinc salts suitable for use in the oral composition of the invention are disclosed in US-A-4,100,269, US-A-4,022,880, 4,160,821 and US-A-4,656,031. These include by way of example, zinc citrate, zinc chloride and zinc sulphate. Examples of other zinc salts that have been proposed are zinc carboxymethyloxysuccinate (US-A-4,144,323), zinc glycinate (US-A-4,339,432), and zinc aspartate (US-A-4,622,220). Zinc citrate is the preferred zinc salt. The amount of the zinc salt used in the oral composition of the invention may be from 0.05% to 1.5%, preferably from 0.1% to 0.7%, calculated as zinc. The balance of the oral composition consists of an orally acceptable medium, the nature of which depends upon the final application form. The oral composition of the invention is preferably in the form of a toothpaste, by which term we include products sometimes referred to as dental creams or gels. Toothpaste usually comprise a suspension of a particulate solid abrasive cleaning agent in a thickened aqueous humectant liquid. In the oral composition of this invention various of the known abrasive cleaning agents can be used but silica abrasives are preferred. A number of forms of silica are already known in the art as being suitable for dentifrice use including silica xerogels, precipitated silicas and crystalline silicas. Such silicas are referred to in US A-3,538,230 and GB-A-2,167,856. Other compatible abrasives include water-insoluble sodium metaphosphate, alumina, calcium pyrophosphate and plastics materials. Alumina abrasives include the hydrated aluminas. A conventional level of abrasive ranging from 5 to 75% by weight of the toothpaste may be used. As is well know, use of various silica abrasives permits the toothpaste to be formulated in the form of a transparent or translucent gel product. Humectants which may be used include glycerol, sorbitol syrup, polyethylene glycol, lactitol, xylitol or hydrogenated corn syrup. The total amount of humectant present will generally range from 10% to 85% by weight of the toothpaste, more usually 20% to 60%. The remaining liquid phase of toothpaste according to the invention mainly comprises water which will usually amount from 5% to 45% by weight of the toothpaste. The amount of water in the toothpaste, including any present in the humectant, will generally be in the range 5% to 60%, such as from 10% to 55% by weight of the toothpaste. Numerous binding or thickening agents have been indicated for use in toothpastes, preferred ones being hydroxymethylcellulose, sodium carboxymethylcellulose and xanthan gum. Others include natural gum binders such as gum tragacanth, gum karaya and gum arabic, Irish moss alginates and carrageenans. Silica thickening agents include the silica aerogels and various precipitated silicas. Mixtures of binders and thickening agents may be used. The amount of binder and thickening agent included in a toothpaste is generally between 0.1 to 10% by weight. Toothpastes generally also comprise a surfactant. Commonly used is sodium lauryl sulphate but others are also known to be suitable. The amount of surfactant is usually within the range 0.5 to 5% by weight of the composition. A variety of other known toothpaste ingredients may also be included in toothpastes formulated in accordance with the present invention. Such ingredients include an anti-caries ingredient such as casein and casein digests, hydroxyapatites, trimetaphosphates, sodium fluoride or sodium monofluorophosphate or other effective fluorine-containing compound; an additional anti-plaque agent such as an antimicrobial compound for example chlorhexidine or 2,4,4'-trichloro-2'-hydroxy-diphenyl ether; sweetening agent such as saccharin; an opacifying agent such as titanum dioxide; a preservative such as formalin; a flavouring agent such as peppermint oil or spearmint oil; a colouring agent; or pH controlling agent such as an acid, base or buffer, for example benzoic acid, to give a pH of from about 4 to about 8, preferably about 5 to about 7; anti-calculus agents such as alkalimetal-pyrophosphates; polymers such as polyvinylmethylether-maleic anhydride copolymers and so on. Preferred oral compositions of this invention contain 500-5000 ppm F, preferably 1000-2500 ppm F, as ionic fluoride or monofluorophosphate. For a further discussion of the formulation of toothpastes reference is made to Harry's Cosmeticology, Seventh Edition 1982, Edited by J.B. Wilkinson and R.J. Moore, pages 609 to 617. The following Example further illustrates the invention: These pastes were made with a green colour, and a similar series was made without the green colour to leave them white. The pastes were tubed on the same day of manufacture. They were subsequently stored at controlled temperatures of 6, 20 and 37°C. Visual observations for discolouration were made after three and six month's storage. Water-extractable vitamin C was also determined, by titration with dichlorophenol indophenol, and with iodine. The following results were obtained. The number of plus signs corresponds with an increasing degree of brown discolouration ranging from very slight discolouration (+) to very severe darkish discolouration (+++++); a minus sign indicates no substantial brown discolouration. The residual water-extractable Vitamin C levels (in %) after six months' storage were:

Claims: An oral composition with a reduced tendency to discolour upon storage and upon exposure to air, comprising in an orally acceptable medium, from 0.05% to 5% by weight of vitamin C or a salt or an ester thereof, and from 1 ppm to 1000 ppm, calculated as copper, of a copper-ions releasing copper compound, characterised in that the composition further contains from 0.01% to 10% by weight of a stannous-ions releasing stannous compound. An oral composition according to claim 1, characterised in that it contains from 0.1-3% by weight of the stannous compound. An oral composition according to claim 1 or 2, characterised in that the stannous compound is stannousfluoride or stannouspyrophosphate or a mixture thereof. An oral composition according to claims 1-3, characterised in that it further contains from 0.05% to 1.5% by weight, calculated as zinc, of a zinc salt. An oral composition according to claim 4, characterised in that the zinc salt is zinc citrate. Use of a stannous-ions releasing stannous compound to reduce the discolouration upon storage and upon exposure to air of an oral composition which contains Vitamin C or a salt or an ester thereof and a copper-ions releasing copper compound in an orally acceptable medium.

Inventors: RILEY, PAUL IAN
Applicants: UNILEVER N.V., UNILEVER PLC
Application year: 1990
Main classification: A61K7
IPC codes: A61K8, A61Q11, A61K31